Dr. Shelbi Atrash
Hematology & Oncology · Charlotte, NC
CMS Profile ID: 1086533 · NPI: 1417105941
F
Payment Grade
High payments ($100,000+). This grade reflects disclosed general payments in CMS Open Payments program year 2024 only.
Total Disclosed Payments
$497,017
Number of Payments
26
Transparency Score
1/5
Payments by Type
| Payment Type | Amount |
|---|---|
| Consulting Fee | $496,408 |
| Food and Beverage | $609 |
Top Paying Companies
| Manufacturer / GPO | Amount |
|---|---|
| PFIZER INC. | $488,423 |
| Janssen Biotech, Inc. | $2,286 |
| E.R. Squibb & Sons, L.L.C. | $2,130 |
| Janssen Scientific Affairs, LLC | $1,908 |
| Karyopharm Therapeutics Inc. | $1,223 |
| GlaxoSmithKline, LLC. | $800 |
Top contributing companies shown; smaller payers may be omitted.
These totals are computed from the official CMS Open Payments program-year 2024 general-payment
file. To see the full, authoritative record for this provider — including research payments and
line-item detail — look them up by name or NPI on the
official CMS Open Payments portal.
What should I ask my doctor?
- Are you a paid speaker or consultant for any pharmaceutical or device company?
- Do any of your prescribing choices reflect relationships with industry?
- Is there an equivalent generic or alternative treatment?